Patents for C07D 498 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms (21,960) |
---|
07/21/2004 | CN1514838A 3,7-diazybicyclo [3.3.1] for mulations as antiarrhytmic compounds |
07/21/2004 | CN1514837A 3,7-diazabicyclo [3.3.1] for mulations as anti arhythmiccompounds |
07/21/2004 | CN1514836A New process for preparation of oxabispidines |
07/21/2004 | CN1514835A Benzoxazepine derivatives and their use as AMPA receptor stimulators |
07/21/2004 | CN1514828A Pyrazole derivatives for treating HIV |
07/21/2004 | CN1158288C Process for quickly synthesizing photochromic spirooxazine by microwave |
07/21/2004 | CN1158073C Application of protein kinase C inhibitor in preparing medicine |
07/20/2004 | US6765009 1,4-Disubstituted benzo-fused compounds |
07/20/2004 | US6765006 Antagonists of amino-3-hydroxy-5-methylisoxazole-4-propionic acid (ampa) ionotropic receptors; neurodegenerative, alzheimer's, and huntington's disease; amyotrophic lateral sclerosis; schizophrenia, excitatory amino acid deficiency |
07/20/2004 | US6764996 Bactericides for infections |
07/20/2004 | CA2286733C Reverse-turn mimetics and methods relating thereto |
07/15/2004 | WO2004058775A1 Method for the continuous production of intermediate products in order to obtain 3-hydroxypyridine compounds |
07/15/2004 | WO2004058774A1 Method for producing pyridoxine or an acid addition salt thereof |
07/15/2004 | WO2004058743A1 Novel substituted nitrogen-containing heterobicycles and use thereof as factor xa inhibitors |
07/15/2004 | WO2004058144A2 Antibacterial agents |
07/15/2004 | WO2004041158A3 Rifalazil compositions and therapeutic regimens |
07/15/2004 | WO2004006846A3 Receptor-type kinase modulators and methods of use |
07/15/2004 | WO2003045312A3 Biosynthetic gene cluster for the maytansinoid antitumor agent ansamitocin |
07/15/2004 | US20040138451 Epindolidione pigments |
07/15/2004 | US20040138282 Agents useful for reducing amyloid precursor protein and treating demantia and methods of use thereof |
07/15/2004 | US20040138222 Post-trauma stress disorder, attention deficit disorders, obsessive compulsive disorders; anxiolytic agents; eating disorders; premenstrual disordrers |
07/15/2004 | US20040138219 Quinolines and nitrogenated derivative therof substituted in 4-position by a piperidine-containing moiety and their use as antibacterial agents |
07/15/2004 | US20040138202 Tetracyclic azepinoindole compounds |
07/15/2004 | CA2511349A1 New substituted nitrogen-containing heterobicycles, the preparation thereof and their use as pharmaceutical compositions |
07/14/2004 | EP1436294A1 Tetracyclic azaindoles and -indolines having serotonin 5-ht2c activity |
07/14/2004 | EP1373273A4 Process for preparing maytansinol |
07/14/2004 | EP1210350B1 Water soluble sdz-rad esters |
07/14/2004 | EP1196170B1 Use of a macrolide compound for the manufacture of a medicament for the treatment of brain damage caused by ischemia or hemorrhage |
07/14/2004 | CN1512983A Compounds and compositions as cathepsins inhibitors |
07/14/2004 | CN1157396C Process for production of levo-ofloxacin |
07/13/2004 | US6762301 Analogues of camptothecin, their use as medicaments and the pharmaceutical compositions containing them |
07/13/2004 | US6762299 Low solubility, good fastness, red to blue colorations; use pigmenting paints, plastics, printing inks, pigment preparations, electrophotographic toners and developers, powder coating, inkjet inks, color filters and cosmetics |
07/13/2004 | US6762181 Broad antibacterial activity including drug resistant staphylococcus aureus (mrsa), pneumococcus (prsp) and enterococcus (vre); safely used in conjuction with nonsteroidal antiinflammatory drugs |
07/13/2004 | US6761981 High efficiency and long service life; marcrocyclic rings comprising tertiary amines contained in a hole transport layer and/or luminescent layer of an electroluminescent device such as flat screen display |
07/13/2004 | CA2192255C Treatment of chlamydia infectious diseases by rifamycin derivative |
07/08/2004 | WO2004056799A2 Substituted 1-piperidin-4-yl-4-pyrrolidin-3-yl-piperazine derivatives and their use as neurokinin antagonists |
07/08/2004 | WO2004045546A3 Water-soluble mesoporphyrin compounds and methods of preparation |
07/08/2004 | US20040133000 Process for the preparation of oxabispidines |
07/08/2004 | US20040132993 Antiviral and antimicrobial guanidine or biguanidine derivatives |
07/08/2004 | US20040132799 Aminoalkoxyindoles and methods of use |
07/08/2004 | US20040132798 containing a benzonitrile group and N-substituted with a tert-butylcarbonylmethyl- or a tert-butyloxycarbonylaminoethyl- group; particularly in a gelling polymer matrix to form modified release composition |
07/08/2004 | US20040132781 Pyrazole compounds useful as protein kinase inhibitors |
07/08/2004 | DE10261272A1 Verfahren zur kontinuierlichen Herstellung von Zwischenprodukten für die Herstellung von 3-Hydroxypyridin-Verbindungen Process for the continuous preparation of intermediates for the preparation of 3-hydroxypyridine compounds |
07/08/2004 | DE10261271A1 Verfahren zur Herstellung von Pyridoxin oder seines Säureadditionssalzes Process for the preparation of pyridoxine or its acid addition salt |
07/08/2004 | CA2789415A1 Macrolides |
07/08/2004 | CA2508657A1 Substituted 1-piperidin-4-yl-4-pyrrolidin-3-yl-piperazine derivatives and their use as neurokinin antagonists |
07/07/2004 | EP0918519B1 Therapeutic treatment for vegf related occular diseases |
07/07/2004 | CN1511157A Novel pyrrole derivatives as pharmaceutical agents |
07/07/2004 | CN1511145A Oxazin (thi)one compounds used as fungicides |
07/07/2004 | CN1511026A Granular preparations of gaboxadol |
07/07/2004 | CN1156480C Water soluble SDZ-RAD esters, its preparation method, use and composition thereof |
07/06/2004 | US6759536 Genetic engineering; polyketides |
07/06/2004 | US6759065 Extraction method, pharmaceutical composition and a cosmetic composition |
07/06/2004 | CA2312206C Novel bicyclic derivatives of amino-pyrazinones, process for preparing them and pharmaceutical compositions containing them |
07/01/2004 | WO2004055025A1 Pure levofloxacin hemihydrate and processes for preparation thereof |
07/01/2004 | WO2004026819A3 OPIATE ANALOGS SELECTIVE FOR THE delta-OPIOID RECEPTOR |
07/01/2004 | US20040127493 Antidepressant azaheterocyclylmethyl derivatives of 4,5-dihydroimidazo[1,4,5-de ][1,4]benzoxazine |
07/01/2004 | US20040127492 Cyclic pyrazoles for the inhibition of mitogen activated protein kinase-activated protein kinase-2 |
07/01/2004 | US20040127482 Substituted heterocycle fused gamma-carbolines |
07/01/2004 | US20040123948 Adjust adhesion at interface of microelectronics packages; shrinkage inhibition |
07/01/2004 | DE10260730A1 Neue substituierte stickstoffhaltige Heterobicyclen, deren Herstellung und deren Verwendung als Arzneimittel New substituted nitrogen containing heterobicycles, their preparation and their use as medicaments |
06/30/2004 | EP1432734A1 Cytokine receptor |
06/30/2004 | EP1432705A2 Dual action antibiotics |
06/30/2004 | EP1432408A1 Pharmaceutical compositions comprising colloidal silicon dioxide |
06/30/2004 | EP1282625B1 Benzoxazines for use in the treatment of parkinson's disease |
06/30/2004 | EP1019408B1 1,2,3,4-TETRAHYDRO-BENZOFURO[3,2-c]PYRIDINE DERIVATIVES |
06/30/2004 | CN1509291A Oxazolo-and-furopyrimidines and their use in medicaments against tumors |
06/30/2004 | CN1509187A Cytotoxic CD44 antibody immunoconjugates |
06/29/2004 | CA2263913C Substituted 6,6-hetero-bicyclic derivatives |
06/24/2004 | WO2004052373A1 Benzoxazin-3-ones and derivatives thereof as inhibitors of pi3k |
06/24/2004 | US20040122230 Opiate analogs selective for the delta -opioid receptor |
06/24/2004 | US20040122063 Ethylenediamine derivatives |
06/24/2004 | US20040122041 Oxazolo, thiazolo and selenazolo [4,5-c]-quinolin-4-amines and analogs thereof |
06/24/2004 | US20040122037 Strong anti-depressant activity without being sedative; serotonin (5-HT) reuptake inhibitor activity in combination with additional alpha 2-adrenoceptor antagonist activity |
06/24/2004 | US20040121996 Benzoxazin-3-ones and derivatives thereof as therapeutic agents |
06/24/2004 | CA2508601A1 Benzoxazin-3-ones and derivatives thereof as inhibitors of pi3k |
06/23/2004 | EP1429776A2 Tricyclic indole derivatives as 5-ht ligands |
06/23/2004 | EP1429765A2 Inhibitors of histone deacetylase |
06/23/2004 | EP1188756B1 Novel azetidine derivative and process for preparation thereof |
06/23/2004 | CN1507449A 1-oxa-3,9-diaza-spiro [5,5] undecan-2-ones derivatives and its use as antagonist of the neurikinin receptor |
06/23/2004 | CN1507446A Broadspectrum 2-amino-benzoxazole sulfonamide HIV protease inhibitors |
06/23/2004 | CN1154651C Method for separating analogous organic compounds |
06/22/2004 | CA2114113C Cardiac output probe assembly |
06/17/2004 | WO2004050645A1 Substituted (thiazol-2-yl) -amide or sulfonamide as glycokinase activators useful in the treatment of type 2 diabetes |
06/17/2004 | WO2004050085A1 Aminoalkoxyindoles as 5-ht6-receptor ligands for the treatment of cns-disorders |
06/17/2004 | WO2004050036A2 Quinolines and nitrogenated derivatives thereof and their use as antibacterial agents |
06/17/2004 | US20040116460 Anticancer agents |
06/17/2004 | US20040116454 Pyrazole compounds useful as protein kinase inhibitors |
06/17/2004 | US20040116445 Substituted thioacetamides |
06/17/2004 | CA2508315A1 Aminoalkoxyindoles as 5-ht6-receptor ligands for the treatment of cns-disorders |
06/17/2004 | CA2498089A1 Substituted (thiazol-2-yl) -amide or sulfonamide as glycokinase activators useful in the treatment of type 2 diabetes |
06/16/2004 | EP1428534A1 Benzofurazan derivatives for enhancing glutamatergic synaptic responses |
06/16/2004 | EP1427720A1 3-substituted-4-pyrimidone derivatives |
06/16/2004 | EP1427709A1 3-substituted-4-pyrimidone derivatives |
06/16/2004 | EP1427457A1 Medical devices containing rapamycin analogs |
06/16/2004 | EP1064942B1 Sustained release preparation of a macrolide |
06/16/2004 | EP0817635B1 Use of thiazepine, oxazepine and diazepine coumpounds for inhibiting hiv, herpesvirus and suppressing the immune system |
06/15/2004 | CA2086642C Method of treating hyperproliferative vascular disease |
06/10/2004 | WO2004048339A1 Isoquinoline compounds and medicinal use thereof |
06/10/2004 | WO2004047837A2 Beta-blockers having antioxidant and nitric oxide-donor activity |